American Heart Journal
Volume 158, Issue 3 , Page e39 , September 2009

Myocardial infarction in saphenous percutaneous intervention: Are we really doing our best?

References 

  1. Bonello L, De Labriolle A, Lemesle G, et al. Prognostic value of procedure-related myocardial infarction according to the universal definition of myocardial infarction in saphenous vein graft interventions. Am.Heart J. 2009;157:894–898
  2. Roffi M, Mukherjee D, Chew DP, et al. Lack of benefit from intravenous platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment for percutaneous interventions of aortocoronary bypass grafts: a pooled analysis of five randomized clinical trials. Circulation. 2002;106:3063–3067
  3. Leborgne L, Cheneau E, Pichard A, et al. Effect of direct stenting on clinical outcome in patients treated with percutaneous coronary intervention on saphenous vein graft. Am Heart J. 2003;146:501–506
  4. Baim DS, Wahr D, George B, et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation. 2002;105:1285–1290
  5. Mehta SK, Frutkin AD, Milford-Beland S, et al. Utilization of distal embolic protection in saphenous vein graft interventions (an analysis of 19,546 patients in the American College of Cardiology–National Cardiovascular Data Registry). Am J Cardiol. 2007;100:1114–1118
  6. Lozano I, Garcia-Camarero T, Carrillo P, et al. Comparison of drug-eluting and bare metal stents in saphenous vein grafts. Immediate and long-term results. Rev Esp Cardiol. 2009;62:39–47
  7. Baz JA, Pinar E, Albarran A, et al. Spanish Cardiac Catheterization and Coronary Intervention Registry. 17th Official report of the Spanish Society of Cardiology Working Group on Cardiac Catheterization and Interventional Cardiology (1990-2007). Rev Esp Cardiol. 2008;61:1298–1314

PII: S0002-8703(09)00474-8

doi: 10.1016/j.ahj.2009.06.016

American Heart Journal
Volume 158, Issue 3 , Page e39 , September 2009

Article Tools